1-179575778-G-C

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The ENST00000367615.9(NPHS2):ā€‹c.87C>Gā€‹(p.Ala29=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00557 in 1,497,754 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A29A) has been classified as Likely benign.

Frequency

Genomes: š‘“ 0.0043 ( 0 hom., cov: 34)
Exomes š‘“: 0.0057 ( 35 hom. )

Consequence

NPHS2
ENST00000367615.9 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: -1.24
Variant links:
Genes affected
NPHS2 (HGNC:13394): (NPHS2 stomatin family member, podocin) This gene encodes a protein that plays a role in the regulation of glomerular permeability. Mutations in this gene cause steroid-resistant nephrotic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-179575778-G-C is Benign according to our data. Variant chr1-179575778-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 260431.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1, Likely_benign=4}.
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 35 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NPHS2NM_014625.4 linkuse as main transcriptc.87C>G p.Ala29= synonymous_variant 1/8 ENST00000367615.9 NP_055440.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NPHS2ENST00000367615.9 linkuse as main transcriptc.87C>G p.Ala29= synonymous_variant 1/81 NM_014625.4 ENSP00000356587 P1Q9NP85-1
NPHS2ENST00000367616.4 linkuse as main transcriptc.87C>G p.Ala29= synonymous_variant 1/71 ENSP00000356588 Q9NP85-2

Frequencies

GnomAD3 genomes
AF:
0.00427
AC:
649
AN:
152076
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000941
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00569
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.00972
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00563
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00480
AC:
486
AN:
101244
Hom.:
1
AF XY:
0.00522
AC XY:
298
AN XY:
57116
show subpopulations
Gnomad AFR exome
AF:
0.00121
Gnomad AMR exome
AF:
0.00331
Gnomad ASJ exome
AF:
0.00192
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00678
Gnomad FIN exome
AF:
0.00793
Gnomad NFE exome
AF:
0.00544
Gnomad OTH exome
AF:
0.00369
GnomAD4 exome
AF:
0.00572
AC:
7694
AN:
1345570
Hom.:
35
Cov.:
37
AF XY:
0.00583
AC XY:
3872
AN XY:
664110
show subpopulations
Gnomad4 AFR exome
AF:
0.000543
Gnomad4 AMR exome
AF:
0.00368
Gnomad4 ASJ exome
AF:
0.00208
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00783
Gnomad4 FIN exome
AF:
0.0105
Gnomad4 NFE exome
AF:
0.00592
Gnomad4 OTH exome
AF:
0.00463
GnomAD4 genome
AF:
0.00426
AC:
649
AN:
152184
Hom.:
0
Cov.:
34
AF XY:
0.00468
AC XY:
348
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.000939
Gnomad4 AMR
AF:
0.00569
Gnomad4 ASJ
AF:
0.00259
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00497
Gnomad4 FIN
AF:
0.00972
Gnomad4 NFE
AF:
0.00563
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00251
Hom.:
0
Bravo
AF:
0.00350
Asia WGS
AF:
0.00116
AC:
4
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 05, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2022NPHS2: BP4, BP7 -
Nephrotic syndrome, type 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsOct 04, 2016- -
Steroid-resistant nephrotic syndrome Benign:1
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Jan 06, 2020- -
NPHS2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 28, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Focal segmental glomerulosclerosis Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMay 01, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.4
DANN
Benign
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12123397; hg19: chr1-179544913; API